CISPLATIN INJECTION BP
Google image searchProduct monograph
Active ingredient
cisplatin, 1 MG/ML
DIN: 02536285
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: SINGLE-USE VIAL
Schedule: Prescription
Company: HIKMA CANADA LIMITED
Date: 23-FEB-2024
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01X — OTHER ANTINEOPLASTIC AGENTS (ATC, ATC/DDD)
- L01XA — Platinum compounds (ATC, ATC/DDD)
- L01XA01 — CISPLATIN (ATC/DDD)
Reference brand drug: Platinol
Pharmaceutical standard: BP
